Evaluation of metabolic syndrome after hematopoietic stem cell transplantation in children and adolescents

Pediatric Blood and Cancer

Volumn 59, Issue 2, 2012, Pages 306-310

  Paris, Claudia ^a   Yates, Lorena ^b   Lama, Pamela ^b   Zepeda, Ana J ^c   Gutiérrez, Daniela ^a   Palma, Julia ^a,b  

^a HOSPITAL LUIS CALVO MACKENNA   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Hematopoietic SCT; Late effects; Metabolic syndrome; Obesity

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTERIAL PRESSURE; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NUTRITIONAL STATUS; OBESITY; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBERTY; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; BODY MASS INDEX; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; METABOLIC SYNDROME X; NEOPLASMS; OBESITY; OVERWEIGHT; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION, AUTOLOGOUS; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84862256998     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24104     Document Type: Article

References (48)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med 2006; 354: 1813- 1826.
2. Palma J, Mosso C, Paris C, et al. Establishment of a pediatric HSCT program in a public hospital in Chile. Pediatr Blood Cancer 2006; 46: 803- 810.
3. Socie G, Salooja N, Cohen A, et al. Non-malignant late effects after allogeneic stem cell transplantation. Blood 2003; 101: 3373- 3385.
4. Van Waas M, Neggers SJ, van der Lelij A, et al. The metabolic syndrome in adult survivors of childhood cancer, a review. J Pediatr Hematol Oncol 2010; 32: 171- 179.
5. Legault L, Bonny Y. Endocrine complications of bone marrow transplantation in children. Pediatr Transplant 1999; 3: 60- 66.
6. Tauchmanova L, Selleri C, De Rosa G, et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 2002; 95: 1076- 1084.
7. Cohen A, Bekassy AN, Gaiero A, et al. Endocrinological late complications after hematopoietic SCT children. Bone Marrow Transplant 2008; 41: S43- S48.
8. Ishiguro H, Yasuda Y, Tomita Y. Long-term follow-up thyroid function in patients who received bone marrow transplantation during childhood and adolescence. J Clin Endocrinol 2004; 89: 5981- 5986.
9. Slatter MA, Gennery AR, Cheetham TD, et al. Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning. Bone Marrow Transplant 2004; 33: 949- 953.
10. Sanders JE, Pritchard S, Mahoney P, et al. Growth and development following marrow transplantation for leukemia. Blood 1986; 68: 1129- 1135.
11. Shankar S, Bunin N. Thomas Jr M. Growth in children undergoing bone marrow transplantation after busulfan and cyclophosphamide conditioning. J Pediatr Hematol Oncol 1996; 18: 362- 366.
12. Tichelli A, Bucher C, Rovó A, et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 2007; 110: 3463- 3471.
13. Lorini R, Cortona L, Scaramuzza A, et al. Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant 1995; 15: 873- 877.
14. Ford ES, Giles WH, Dietz W. Prevalence of the metabolic syndrome among US adults: Findings from the third national Health and nutrition examination survey. JAMA 2002; 287: 356- 359.
15. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 2004; 27: 2444- 2449.
16. Ministerio de salud. Gobierno de Chile. Encuesta nacional de salud (2003) Accessed November 28, 2009 Available at
17. Cook S, Weitzman M, Auinger P, et al. Prevalence of a metabolic syndrome phenotype in adolescents. Arch Pediatr Adolsec Med 2003; 157: 821- 827.
18. De Ferranti SD, Gauvreau K, Ludwig D, et al. Prevalence of the metabolic syndrome in American adolescents. Findings from the third national health and nutrition examination survey. Circulation 2004; 110: 2494- 2497.
19. Duncan GE, Sierra ML, Xiao-Hua Z. Prevalence and trends of a metabolic syndrome phenotype among US adolescents, 1999-2000. Diabetes Care 2004; 27: 2438- 2443.
20. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 3: 1595- 1607.
21. Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: The Bruneck study. Diabetes 1998; 47: 1643- 1649.
22. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683- 689.
23. Caballero EA. Endothelial dysfunction in obesity and insulin resistance: A road to diabetes and heart disease. Obesity Res 2003; 11: 1278- 1289.
24. Cornier MA, Dabelea D, Hernández TL, et al. The metabolic syndrome. Endocr Rev 2008; 29: 777- 822.
25. Grundy S, Brewer H, Cleeman J, et al. Definition of metabolic syndrome. Report of the National Heart, Lung and Blood Institute/American Heart Association Conference in Scientific Issues Related to Definition. Circulation 2004; 109: 433- 438.
26. Grundy S, Cleeman J, Daniels S, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005; 112: 2735- 2752.
27. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 2008; 31: S12- S54.
28. Fernández JR, Reeden DT, Pietrobelli A, et al. Waist circumference percentiles in nationally representative sample of African-American, European-American and Mexican-American children and adolescents. J Pediatr 2004; 145: 439- 444.
29. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555- 573.
30. Pizarro T, Rodríguez L, Atalah E, et al. Norma técnica de evaluación nutricional del niño de 6 a 18 años. Reporte técnico. Rev Chil Nutr 2004; 31: 128- 137.
31. WHO. Obesity: Preventing and management the global epidemic. Report of a WHO Consultation on Obesity. World Health Organ Tech Rep Ser 2000; 894: 1- 253.
32. Tanner JM. Growth at adolescence with a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity, 2nd edition. Oxford: Blackwell Scientific Publications; 1962. 325.
33. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestation of graft-versus-host disease in human recipients marrow transplantation from HLA-matched sibling donors. Transplantation 1974; 18: 295- 304.
34. Steinberger J, Daniels S, Eckel RH, et al. Progress and challenges in metabolic syndrome in children and adolescents. A Scientific Statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009; 119: 628- 647.
35. Dietz WH. Overweight and precursors of type 2 diabetes mellitus in children and adolescent. J Pediatr 2001; 138: 453- 454.
36. Weiss R, Dziura J, Burgert T, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362- 2374.
37. Burrows R, Leiva L, Weistaub G, et al. Síndrome metabólico en niños y adolescentes: Asociación con sensibilidad insulínica y con magnitud de y distribución de la obesidad. Rev Med Chile 2007; 135: 174- 181.
38. Majhail NS, Flowers ME, Ness KK, et al. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2009; 43: 49- 54.
39. Annaloro C, Usardi P, Airaghi L, et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant 2008; 41: 797- 804.
40. Taskinen M, Saarinen-Pihkala UM, Hovi L, et al. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 2000; 356: 993- 997.
41. Shalitin S, Phillip M, Stein J, et al. Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant 2006; 37: 1109- 1117.
42. Traggiai C, Stanhope R, Nussey S, et al. Diabetes mellitus after bone marrow transplantation during childhood. Med Pediatr Oncol 2003; 40: 128- 129.
43. Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: A report from the bone marrow transplantation survivors study. Blood 2007; 109: 1765- 1772.
44. Bonanomi S, Gaiero A, Masera N, et al. Distinctive characteristics of diabetes mellitus after hematopoietic cell transplantation during childhood. Pediatr Transplant 2006; 10: 461- 465.
45. Hoffmeister PA, Storer BE, Sanders JE. Diabetes mellitus in long-term survivors of pediatric hematopoietic cell transplantation. J Pediatr Hematol Oncol 2004; 26: 81- 90.
46. Schmitz KH, Jacobs DR, Hong CP, et al. Association of physical activity with insulin sensitivity in children. Int J Obes Relat Metab Disord 2002; 26: 1310- 1316.
47. Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol 2007; 157: 545- 559.
48. Rike AH, Mogilishetty G, Alloway RR, et al. Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation: Comparison of early steroid withdrawal and chronic steroids. Clin Transplant 2008; 22: 229- 235.